Jason M. Melear
Jason M. Melear publishes mostly in Oncology, Pathology and Forensic Medicine and Genetics, on topics such as Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment and CAR-T cell therapy research.
- World rank
- #2,066,151 of 7,710,434 ranked researchers
- Rank in United States
- #624,896 of 1,627,098
- Works
- 84
- Citations
- 1.2k
- Citations per work
- 14.4
What does Jason M. Melear research?
Jason M. Melear's work is mostly in Medicine (79%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6779.2%
- Medicine6779.2%
- Everything else1720.8%
- 1Oncology22% of their works
- 2Pathology and Forensic Medicine16% of their works
- 3Genetics15% of their works
- 4Hematology11% of their works
- 5Pulmonary and Respiratory Medicine10% of their works
- 6Radiology, Nuclear Medicine and Imaging6% of their works
Research topics
Which keywords describe Jason M. Melear's research?
The keywords of their largest research topics: Rituximab, Lymphoma, Chronic Lymphocytic Leukemia, Classification, Genomic Aberrations, Molecular Profiling, CAR T Cells and Chimeric Antigen Receptor.
- HER2
- Imatinib
- Therapeutic Antibodies
- International Myeloma Working Group
- EGFR Mutations
- Chimeric Antigen Receptor
- Molecular Profiling
- Classification
- Lymphoma
- Rituximab
- Chronic Lymphocytic Leukemia
- Genomic Aberrations
- CAR T Cells
- Diagnosis Criteria
- Fc Receptors
- Targeted Therapy
- BCR-ABL
- Breast Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Rituximab662 topics
- Lymphoma482 topics
- Chronic Lymphocytic Leukemia331 topic
- Classification331 topic
- Genomic Aberrations331 topic
- Molecular Profiling331 topic
- CAR T Cells151 topic
- Chimeric Antigen Receptor151 topic
- Diagnosis Criteria121 topic
- EGFR Mutations121 topic
- Fc Receptors121 topic
- International Myeloma Working Group121 topic
- Targeted Therapy121 topic
- Therapeutic Antibodies121 topic
- BCR-ABL91 topic
- Imatinib91 topic
- Breast Cancer61 topic
- HER261 topic
Where does Jason M. Melear work?
Jason M. Melear's main affiliation in the publication record is Texas Oncology, United States.
How many publications and citations does Jason M. Melear have?
OpenAlex counts 84 works and 1,212 citations for Jason M. Melear, an h-index of 14, ranking #2,066,151 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jason M. Melear. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.